European Commission Steps Further Towards ‘Ambitious’ Pharma Legislation Reform
Considering Proposals To Allow Earlier Market Entry For Generics And Biosimilars
The incentives system, access to medicines, future proofing for novel products and antimicrobial resistance are just some of the topics included in a new consultation.
